DK1748785T3 - Peptider til modulering af bruskhomeostase - Google Patents
Peptider til modulering af bruskhomeostaseInfo
- Publication number
- DK1748785T3 DK1748785T3 DK05745198T DK05745198T DK1748785T3 DK 1748785 T3 DK1748785 T3 DK 1748785T3 DK 05745198 T DK05745198 T DK 05745198T DK 05745198 T DK05745198 T DK 05745198T DK 1748785 T3 DK1748785 T3 DK 1748785T3
- Authority
- DK
- Denmark
- Prior art keywords
- peptides
- seq
- cartilage homeostasis
- modulating
- linear
- Prior art date
Links
- 210000000845 cartilage Anatomy 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 230000013632 homeostatic process Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108010069514 Cyclic Peptides Proteins 0.000 abstract 2
- 102000001189 Cyclic Peptides Human genes 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 230000006378 damage Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200400692 | 2004-04-30 | ||
| PCT/EP2005/004728 WO2005105131A1 (en) | 2004-04-30 | 2005-04-29 | Modulation of cartilage homeostasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1748785T3 true DK1748785T3 (da) | 2008-11-24 |
Family
ID=34966657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK05745198T DK1748785T3 (da) | 2004-04-30 | 2005-04-29 | Peptider til modulering af bruskhomeostase |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20070225215A1 (da) |
| EP (1) | EP1748785B1 (da) |
| JP (1) | JP2007535517A (da) |
| CN (1) | CN1950102B (da) |
| AT (1) | ATE403434T1 (da) |
| CA (1) | CA2564968A1 (da) |
| DE (1) | DE602005008735D1 (da) |
| DK (1) | DK1748785T3 (da) |
| ES (1) | ES2311989T3 (da) |
| WO (1) | WO2005105131A1 (da) |
| ZA (1) | ZA200609223B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2824204T3 (es) * | 2013-01-22 | 2021-05-11 | Lycored Ltd | Composiciones que comprenden un concentrado de tomate claro tratado térmicamente |
| RU2547787C1 (ru) * | 2013-12-16 | 2015-04-10 | Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт травматологии и ортопедии имени В.Д. Чаклина" Министерства здравоохранения Российской Федерации | Способ оптимизации состояния суставного хряща при экспериментальном иммобилизационном остеопорозе |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9904237D0 (sv) * | 1999-11-22 | 1999-11-22 | Ana Mar Diagnostics Ab | New compound |
-
2005
- 2005-04-29 WO PCT/EP2005/004728 patent/WO2005105131A1/en active IP Right Grant
- 2005-04-29 JP JP2007509990A patent/JP2007535517A/ja active Pending
- 2005-04-29 ZA ZA200609223A patent/ZA200609223B/en unknown
- 2005-04-29 CN CN2005800139013A patent/CN1950102B/zh not_active Expired - Fee Related
- 2005-04-29 US US11/579,052 patent/US20070225215A1/en not_active Abandoned
- 2005-04-29 CA CA002564968A patent/CA2564968A1/en not_active Abandoned
- 2005-04-29 AT AT05745198T patent/ATE403434T1/de not_active IP Right Cessation
- 2005-04-29 DE DE602005008735T patent/DE602005008735D1/de active Active
- 2005-04-29 DK DK05745198T patent/DK1748785T3/da active
- 2005-04-29 EP EP05745198A patent/EP1748785B1/en not_active Not-in-force
- 2005-04-29 ES ES05745198T patent/ES2311989T3/es active Active
-
2009
- 2009-03-09 US US12/381,211 patent/US8158577B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1950102B (zh) | 2012-05-23 |
| JP2007535517A (ja) | 2007-12-06 |
| ZA200609223B (en) | 2008-06-25 |
| US20090291879A1 (en) | 2009-11-26 |
| ES2311989T3 (es) | 2009-02-16 |
| DE602005008735D1 (de) | 2008-09-18 |
| EP1748785B1 (en) | 2008-08-06 |
| ATE403434T1 (de) | 2008-08-15 |
| CN1950102A (zh) | 2007-04-18 |
| CA2564968A1 (en) | 2005-11-10 |
| EP1748785A1 (en) | 2007-02-07 |
| WO2005105131A1 (en) | 2005-11-10 |
| US20070225215A1 (en) | 2007-09-27 |
| US8158577B2 (en) | 2012-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1171465T3 (da) | Analoger til gastroinhibitorisk peptid og deres anvendelse til behandling af diabetes | |
| DE60330767D1 (de) | Ferritinfusionsproteine zur verwendung für impfstoffe und andere anwendungen | |
| RS53505B1 (en) | OXYTOMODULIN PEPTIDE ANALOG | |
| CO6251321A2 (es) | Polipeptidos dominios variable s de anticuerpos y antagonistas | |
| DE60332358D1 (de) | Protease-resistente modifizierte interferon alpha polypeptide | |
| ATE386538T1 (de) | Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden | |
| ES2160485B1 (es) | Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen. | |
| ATE551048T1 (de) | Proteinhydrolysate enthaltende kosmetische zusammensetzungen | |
| MX2008009493A (es) | Peptido novedoso y uso del mismo. | |
| HRP20050024A2 (en) | Pegylated t20 polypeptide | |
| DE602005019416D1 (de) | Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid | |
| NZ607892A (en) | Tfpi inhibitors and methods of use | |
| CY1108599T1 (el) | Η απλιδινη στην αντιμετωπιση του πολλαπλου μυελωματος | |
| SE0302304D0 (sv) | Novel compounds | |
| NZ508505A (en) | Treatment of wounds using an Egr-1 transcription factor polypeptide | |
| ATE281159T1 (de) | Verwendung von aminosäure zur herstellung von arzneimitteln zur behandlung von insulinresistenz | |
| DK1748785T3 (da) | Peptider til modulering af bruskhomeostase | |
| NO20055512L (no) | Terapi eller prevensjon av respiratoriske, virale infeksjoner med alfa-tyimosinpeptider | |
| ATE474589T1 (de) | Angiogene peptide und ihre verwendungen | |
| ATE484290T1 (de) | Peptid mit antitumoraler wirkung | |
| RS52448B (en) | ANTITUMOR PHARMACEUTICAL COMPOSITION CONTAINING SERALIZIN POLYPEPTIDE FRAGMENTS | |
| ATE410448T1 (de) | Neues peptid und pharmazeutische zusammensetzung, die dieses peptid enthält | |
| EA200801077A1 (ru) | Антагонисты взаимодействия pf4 и rantes | |
| NZ591827A (en) | Biologically active peptides comprising PTTKTYFPHF and their uses in the manufacture of a medicament for modulating immune reaction in a radiotherapy-induced immuno-compromised subject | |
| ATE518878T1 (de) | Antimikrobielle peptide |